Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast

Purpose: To detail the outcome, in terms of local recurrence, local invasive recurrence, distant recurrence, and breast cancer mortality for patients previously treated for ductal carcinoma in situ (DCIS). Patients and Methods: Clinical, pathologic, and outcome data were collected prospectively for 707 patients with DCIS accrued from 1972 through June 1997. Results: There were 74 local recurrences; 39 were noninvasive (DCIS) and 35 were invasive, Fifty-one percent of patients with invasive recurrences presented with stage 1 disease; the remainder presented with more advanced disease, Invasive local recurrence after mastectomy was a rare event that occurred in 0.8% of patients. Invasive recurrence after breast preservation was more common and occurred in 7.4% of patients. The 8-year probability of breast cancer mortality after breast preservation was 2.1%, a number that is likely to increase with longer follow-up. The 8-year breast cancer-specific mortality and distant-disease probability for the subgroup of 74 patients with locally recurrent disease was 8.8% and 20.8%, respectively, If only the 35 invasive recurrences are considered as events, the 8-year breast cancer-specific mortality and distant disease probability was 14.4% and 27.1%, respectively. Conclusion: Invasive local recurrence after breast preservation treatment for patients with DCIS is a serious event that converts patients with previous stage 0 disease to patients with disease that ranges from stage I to stage IV, These results, however, indicate that most DCIS patients with local recurrence can be salvaged. (C) 1998 by American Society of Clinical Oncology.